Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells-Reference-Cited by-同舟云学术

Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells

Published:2016-11 Issue:5 Volume:45 Page:945-946
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Maher John,Wilkie Scott,Davies David M.,Arif Sefina,Picco Gianfranco,Julien Sylvain,Foster Julie,Burchell Joy,Taylor-Papadimitriou Joyce

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference7 articles.

1. Driving CARs into Sweet Roads: Targeting Glycosylated Antigens in Cancer;Blidner;Immunity,2016

2. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin;Burchell;Cancer Res.,1987

3. Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia;Imai;Leukemia,2004

4. Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma;Posey;Immunity,2016

5. Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?;van der Stegen;J. Immunol.,2013

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancer;Science Advances;2024-08-30

2. CAR-T treatment for cancer: prospects and challenges;Frontiers in Oncology;2023-12-05

3. Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors;Cancers;2023-07-08

4. In situ MUC1-specific CAR engineering of tumor-supportive macrophages stimulates tumoricidal immunity against pancreatic adenocarcinoma;Nano Today;2023-04

5. Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer;Cancers;2022-11-06